Drug hydroxylator phenotype in Hungary

Szorady, I; Sánta, A

doi:10.1007/bf00607584

Eur J Clin Pharmacol

1987

DOI: 10.1007/bf00607584

|View full text |Cite

Drug hydroxylator phenotype in Hungary

I Szorady

A Sánta

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1990

1998

Publication Types

Select...

Article6

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 7 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, in this worldwide reconstruction of human evolution, some European populations (Basques, Finns, Hungarians and Estonians) seem to differ both genetically and linguistically from the others. Previous studies of polymorphic drug metabolism among Hungarians (Szorady & Santa 1987) and Finns (Syvalahti et al 1986;Arvela et nl. 1988) were limited to debrisoquine hydroxylation phenotyping and did not reveal significant differences from the average European population (Alvan et al 1990).…”

mentioning

confidence: 96%

Polymorphism of Debrisoquine and Mephenytoin Hydroxylation among Estonians

Kiivet

Svensson

Sjöqvist

1993

Pharmacology & Toxicology

View full text Add to dashboard Cite

Debrisoquine and S-mephenytoin hydroxylation polymorphisms were studied in 156 unrelated native Estonians. The hydroxylation phenotypes were assessed by coadministration of mephenytoin with debrisoquine or dextromethorphan. The frequency of the poor metaboliser phenotype of debrisoquine/dextromethorphan was 4.5% (95% confidence interval 1.2-7.8%), and that of mephenytoin was 3.9% (95% confidence interval 0.9-6.9%) among Estonians, which is very similar to what has been reported in other Caucasian populations.

show abstract

mentioning

confidence: 96%

Polymorphism of Debrisoquine and Mephenytoin Hydroxylation among Estonians

Kiivet

Svensson

Sjöqvist

1993

Pharmacology & Toxicology

View full text Add to dashboard Cite

show abstract

Polymorphism of debrisoquine oxidation in New Zealand Caucasians

Wanwimolruk

Denton

Ferry

et al. 1992

Eur J Clin Pharmacol

View full text Add to dashboard Cite

Dextromethorphan O-demethylation polymorphism in Jordanians

Irshaid

Al-Hadidi

Rawashdeh

1993

Eur J Clin Pharmacol

View full text Add to dashboard Cite

The O-demethylation of dextromethorphan (DMT) to dextrorphan (DRP) was studied in 241 unrelated, healthy Jordanian volunteers (171 males, 70 females). Urine was collected for 8 h following a single oral dose of DMT bromhydrate 30 mg. A thin-layer chromatographic (TLC) technique was used to identify the metaboliser phenotype. The frequency of the poor metaboliser phenotype was found to be 2.9% (approximate 95% confidence interval 0.8-5.0%). Applying the Hardy-Weinberg Law, the frequency of the recessive autosomal gene controlling poor metabolism was 0.17 (95% confidence interval 0.108-0.232).

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Drug hydroxylator phenotype in Hungary

Cited by 7 publications

References 5 publications

Polymorphism of Debrisoquine and Mephenytoin Hydroxylation among Estonians

Polymorphism of Debrisoquine and Mephenytoin Hydroxylation among Estonians

Polymorphism of debrisoquine oxidation in New Zealand Caucasians

Dextromethorphan O-demethylation polymorphism in Jordanians

Contact Info

Product

Resources

About